Kidney nerve treatment studied for stubborn heart rhythm problem
NCT ID NCT05817318
First seen Nov 18, 2025 · Last updated Jun 22, 2026 · Updated 29 times
Summary
This study looked at whether a procedure called renal denervation could help people with recurrent atrial fibrillation (an irregular heartbeat) that keeps coming back even after standard treatment. The procedure uses energy to calm certain nerves near the kidneys. Only 6 people took part before the study was stopped early, so we cannot draw firm conclusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inselspital Bern
Bern, 3010, Switzerland
-
Universitätsspital Basel
Basel, 4031, Switzerland
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
renal denervation (a medical device procedure that uses energy to calm nerves near the kidneys)
What this could lead to
If it worked, this could offer a new option for people whose atrial fibrillation keeps coming back after standard ablation.
What could go wrong
The trial was terminated early with only 6 participants, so results are very limited. It is unclear if the procedure is effective or safe for this use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.